Abstract
Aim. It was conducted a comparative determination of matrix metalloproteinase- 9 in 116 patients with ischemic cerebral infarction, hemorrhagic stroke, ischemic stroke with hemorrhagic transformation in patients with circulatory encephalopathy.Methods and results. The study determined that the concentration of MMP-9 in patients with hemorrhagic stroke and ischemic stroke with hemorrhagic transformation is higher than in patients with ischemic stroke.Conclusion. It was determined that in patients with ischemic stroke , in which MMP- 9 is below 50 ng / ml , hemorrhagic transformation were not observed regardless of the severity of the condition and volume of the lesion.
Highlights
С целью определения содержания протеолитического фермента ММП-9 обследовали 116 пациентов с мозговым ишемическим инфарктом, геморрагическим инсультом, ишемическим инсультом с геморрагической трансформацией, а также с дисциркуляторной энцефалопатией
The study determined that the concentration of MMP-9 in patients with hemorrhagic stroke and ischemic stroke with hemorrhagic transformation is higher than in patients with ischemic stroke
It was determined that in patients with ischemic stroke, in which MMP- 9 is below 50 ng / ml, hemorrhagic transformation were not observed regardless of the severity of the condition and volume of the lesion
Summary
It was determined that in patients with ischemic stroke , in which MMP- 9 is below 50 ng / ml , hemorrhagic transformation were not observed regardless of the severity of the condition and volume of the lesion. 1) показали, что на первые сутки заболевания концентрация ММП-9 у больных ИИ, ГИ и ИИГТ достоверно повышалась на 59,3% (р
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
